December 15, 2016
Pfizer/Astellas’s cancer drug study fails
Pfizer and Astellas Pharma have announced the Phase 4 PLATO study, evaluating the efficacy and safety of continued treatment with…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
December 15, 2016
Biocartis CE-marks Idylla NRAS-BRAF Mutation Test
Biocartis has CE-marked its solid biopsy Idylla NRAS-BRAF Mutation Test. On Thursday, Biocartis said that, together with the CE-marked Idylla…
December 15, 2016
PureTech health finishes tolerability testing of KarXT for schizophrenia and Alzheimer’s
Karuna Pharmaceuticals and a subsidiary of PureTech Health have finished studying antipsychotic for schizophrenia and Alzheimer’s disease – KarXT. The…
December 15, 2016
FDA nods to Pfizer’s skin disease drug
U.S. Food and Drug Administration (FDA) has approved Pfizer’s Eucrisa (crisaborole) ointment 2%, a novel non-steroidal topical phosphodieterase-4 (PDE-4) inhibitor…
December 14, 2016
Horizon’s biomanufacturing business boosts revenue
Horizon Discovery Group has provided an update on the commercial operation of its Biomanufacturing business with significant growth in cell…
December 14, 2016
J&J shareholding in Biocartis decreases
Johnson&Johnson has decreased its shareholding in Biocartis, the Belgian drugmaker said on Wednesday. In a disclosure of a transparency notification,…
December 14, 2016
Genticel: two year trial of HPV16/18 immunotherapeutic candidate fails
Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), has…
December 14, 2016
Sphere Medical launches next generation analyser, Proxima 4
Sphere Medical Holding, an innovative point-of-care monitoring and diagnostic devices company, has announced the launch of Proxima 4 in Europe.
December 14, 2016
FDA welcomes Obama signing Cures Act
Barack Obama has in his last days of presidency signed into law the 21st Century Cures Act, which is going…
December 13, 2016
Eli Lilly cuts insulin prices
Eli Lilly has announced that people who use Lilly insulin will be able to access discounted prices for their purchases…